MedPath

Clinical and laboratory study on the effects of green tea on the treatment of patients with Smear positive TB

Not Applicable
Conditions
Respiratory Tuberculosis.
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
Registration Number
IRCT201212232602N11
Lead Sponsor
Research Council of Golestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
88
Inclusion Criteria

Definitive diagnosis of TB according to Ministry of Health criteria; Location in Golestan Province ; treatment of patients under DOTS strategy; Age 15 years and over; Willingness to cooperate in study
Exclusion criteria : Allergic symptoms or side effects of green tea consumption; Severe changes in liver function tests due to anti-TB drugs; Side-effects of anti-TB drugs

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sputum smear conversion. Timepoint: from day 20 to 60 every 10 days. Method of measurement: microscopic smear of sputum.
Secondary Outcome Measures
NameTimeMethod
Hemoglobin. Timepoint: begining of treatment and end of second month. Method of measurement: laboratory measurement.;Transferrin receptor gene expression. Timepoint: begining of treatment and end of second month. Method of measurement: real time PCR.;Hepcidin gene expression. Timepoint: begining of treatment and end of second month. Method of measurement: real time PCR.;TIBC. Timepoint: begining of treatment and end of second month. Method of measurement: laboratory measurement.;Transferrin. Timepoint: begining of treatment and end of second month. Method of measurement: laboratory measurement.;Ferritin. Timepoint: begining of treatment and end of second month. Method of measurement: laboratory measurement.
© Copyright 2025. All Rights Reserved by MedPath